For: | Glebe D. Recent advances in hepatitis B virus research: A German point of view. World J Gastroenterol 2007; 13(1): 8-13 [PMID: 17206750 DOI: 10.3748/wjg.v13.i1.8] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v13/i1/8.htm |
Number | Citing Articles |
1 |
Jing You, Hutcha Sriplung, Alan Geater, Virasakdi Chongsuvivatwong, Lin Zhuang, Hong-Ying Chen, Lan Yu, Bao-Zhang Tang, Jun-Hua Huang. Effect of viral load on T-lymphocyte failure in patients with chronic hepatitis B. World Journal of Gastroenterology 2008; 14(7): 1112-1119 doi: 10.3748/wjg.14.1112
|
2 |
Alexander K. Andrianov, Daniel P. DeCollibus, Helice A. Gillis, Henry H. Kha, Alexander Marin, Mark R. Prausnitz, Lorne A. Babiuk, Hugh Townsend, George Mutwiri. Poly[di(carboxylatophenoxy)phosphazene] is a potent adjuvant for intradermal immunization. Proceedings of the National Academy of Sciences 2009; 106(45): 18936 doi: 10.1073/pnas.0908842106
|
3 |
Siyu Li, Na Li, Shanru Yang, Haiyan Deng, Yanguo Li, Yixuan Wang, Jiaqiang Yang, Jiaxin Lv, Lan Dong, Guansen Yu, Xin Hou, Geng Wang. The study of immune checkpoint inhibitors in chronic hepatitis B virus infection. International Immunopharmacology 2022; 109: 108842 doi: 10.1016/j.intimp.2022.108842
|
4 |
AmirReza Hesari, Faezeh Ghasemi, Reza Salarinia, Hamed Biglari, Agheel Tabar Molla Hassan, Vali Abdoli, Hamed Mirzaei. Effects of curcumin on NF‐κB, AP‐1, and Wnt/β‐catenin signaling pathway in hepatitis B virus infection. Journal of Cellular Biochemistry 2018; 119(10): 7898 doi: 10.1002/jcb.26829
|
5 |
David S. Goodsell. The Molecular Perspective: Hepatitis B Virus. The Oncologist 2007; 12(5): 516 doi: 10.1634/theoncologist.12-5-516
|
6 |
Meilong Shen, Shixia Wang, Guohong Ge, Yiping Xing, Xiuwen Ma, Zuhu Huang, Shan Lu. Profiles of B and T cell immune responses elicited by different forms of the hepatitis B virus surface antigen. Vaccine 2010; 28(45): 7288 doi: 10.1016/j.vaccine.2010.08.081
|
7 |
Haotian Yu, Zhaohua Hou, Qiuju Han, Cai Zhang, Jian Zhang. The anti-HBV effect mediated by a novel recombinant eukaryotic expression vector for IFN-α. Virology Journal 2013; 10(1) doi: 10.1186/1743-422X-10-270
|
8 |
Yang-Xia Li, Yan-Li Ren, Hai-Jing Fu, Ling Zou, Ying Yang, Zhi Chen, Isabelle A Chemin. Hepatitis B Virus Middle Protein Enhances IL-6 Production via p38 MAPK/NF-κB Pathways in an ER Stress-Dependent Manner. PLOS ONE 2016; 11(7): e0159089 doi: 10.1371/journal.pone.0159089
|
9 |
Xingfei Pan, Ka Zhang, Xiaoan Yang, Jiayi Liang, Haixia Sun, Xuejun Li, Yong Zou, Qingqiang Xu, Geng An, Gang Li, Qihuan Xu, Matti Sällberg. Relapse Rate and Associated-Factor of Recurrence after Stopping NUCs Therapy with Different Prolonged Consolidation Therapy in HBeAg Positive CHB Patients. PLoS ONE 2013; 8(7): e68568 doi: 10.1371/journal.pone.0068568
|
10 |
Yajing Liu, Yanfang Zhao, Xin Zhai, Xiuping Liu, Lixue Sun, Yanxia Ren, Ping Gong. Synthesis and Anti‐HBV Activities Evaluation of New Ethyl 8‐Imidazolylmethyl‐7‐hydroxyquinoline‐3‐carboxylate Derivatives in vitro. Archiv der Pharmazie 2008; 341(7): 446 doi: 10.1002/ardp.200800035
|
11 |
Dieter Glebe, Andreas Geipel. Selected Phenotypic Assays Used to Evaluate Antiviral Resistance and Viral Fitness of Hepatitis B Virus and Its Variants. Intervirology 2014; 57(3-4): 225 doi: 10.1159/000360950
|
12 |
Mengxin Lin, Ruyi Guo, Cuiping Ma, Dawu Zeng, Zhijun Su. Manganese Breaks the Immune Tolerance of HBs-Ag. Open Forum Infectious Diseases 2021; 8(2) doi: 10.1093/ofid/ofab028
|
13 |
María L. Cuestas, Verónica L. Mathet, José R. Oubiña, Alejandro Sosnik. Drug Delivery Systems and Liver Targeting for the Improved Pharmacotherapy of the Hepatitis B Virus (HBV) Infection. Pharmaceutical Research 2010; 27(7): 1184 doi: 10.1007/s11095-010-0112-z
|
14 |
Karina Scaramuzzi, Denise Cristina André Oliveira, Luciana Vieira Carvalho, Denise Vilarinho Tambourgi, Elisabeth Christina Nunes Tenório, Marisa Rizzi, Juliana Mussalem, Márcia Carvalho de Abreu Fantini, Viviane Fongaro Botosso, Osvaldo Augusto Sant´Anna. Nanostructured SBA-15 silica as an adjuvant in immunizations with hepatitis B vaccine. Einstein (São Paulo) 2011; 9(4): 436 doi: 10.1590/s1679-45082011ao2162
|
15 |
Fengchao Xu, Hongxiao Song, Beiying An, Qingfei Xiao, Genhong Cheng, Guangyun Tan. NF-κB-Dependent IFIT3 Induction by HBx Promotes Hepatitis B Virus Replication. Frontiers in Microbiology 2019; 10 doi: 10.3389/fmicb.2019.02382
|
16 |
Kyung-Yil Lee. Pediatric respiratory infections byMycoplasma pneumoniae. Expert Review of Anti-infective Therapy 2008; 6(4): 509 doi: 10.1586/14787210.6.4.509
|
17 |
Richard S Tedder, Sara L Bissett, Richard Myers, Samreen Ijaz. The ‘Red Queen’ Dilemma – Running to Stay in the Same Place: Refections on the Evolutionary Vector of HBV in Humans. Antiviral Therapy 2013; 18(3_part_2): 489 doi: 10.3851/IMP2655
|
18 |
C.‐Thomas Bock, Joseph Torresi, Kris Kowdley, Geoffrey McCaughan, Christian Trautwein. Closing the door on hepatitis B†. Hepatology 2008; 48(1): 338 doi: 10.1002/hep.22447
|
19 |
Yu-Fang Chen, Chin-Liew Chong, Yi-Chieh Wu, Yi-Ling Wang, Kuen-Nan Tsai, Tzer-Min Kuo, Ming-Hsiang Hong, Cheng-po Hu, Mong-Liang Chen, Yu-Chi Chou, Chungming Chang, Ming-Lung Yu. Doxorubicin Activates Hepatitis B Virus Replication by Elevation of p21 (Waf1/Cip1) and C/EBPα Expression. PLOS ONE 2015; 10(6): e0131743 doi: 10.1371/journal.pone.0131743
|
20 |
Surya Agung Priyambada, Ryo Misaki, Toru Okamoto, Yuta Okamoto, Takao Ohashi, Keiji Ueda, Yoshiharu Matsuura, Kazuhito Fujiyama. Cell surface N-glycan alteration in HepAD38 cell lines expressing Hepatitis B virus. Virus Research 2017; 238: 101 doi: 10.1016/j.virusres.2017.06.003
|
21 |
Emmet B. Keeffe, Douglas T. Dieterich, Jean–Michel Pawlotsky, Yves Benhamou. Chronic Hepatitis B: Preventing, Detecting, and Managing Viral Resistance. Clinical Gastroenterology and Hepatology 2008; 6(3): 268 doi: 10.1016/j.cgh.2007.12.043
|
22 |
Hui Feng, Jürgen Beck, Michael Nassal, Kang-hong Hu, Wang-Shick Ryu. A SELEX-Screened Aptamer of Human Hepatitis B Virus RNA Encapsidation Signal Suppresses Viral Replication. PLoS ONE 2011; 6(11): e27862 doi: 10.1371/journal.pone.0027862
|
23 |
Christiane Guguen-Guillouzo, Andre Guillouzo. Hepatocytes. Methods in Molecular Biology 2010; 640: 1 doi: 10.1007/978-1-60761-688-7_1
|
24 |
Mehmet Sami Serin, Ebru Bekiroglu, Serpil Polat, Aylin Dogen, Seda Tezcan, Gonul Aslan, Orhan Sezgin, Engin Altintas, Gurol Emekdas, Enver Ucbilek. Detection of hepatitis B virus polymerase gene variants associated with Lamivudine, Adefovir and Entecavir resistance and some undefined mutations isolated from chronic hepatitis B patients in the south of Turkey. Molecular Genetics, Microbiology and Virology 2010; 25(4): 178 doi: 10.3103/S0891416810040075
|
25 |
AM Thabit, KA Al-Moyed, MS Al-Balushi, SS Hasson, TA Sallam. Occult hepatitis B virus among chronic liver disease patients in Yemen. Asian Pacific Journal of Tropical Disease 2012; 2(1): 4 doi: 10.1016/S2222-1808(12)60002-4
|
26 |
Vivek K. Chaturvedi, Anshuman Singh, Sushil K. Dubey, Helal F. Hetta, James John, M.P. Singh. Molecular mechanistic insight of hepatitis B virus mediated hepatocellular carcinoma. Microbial Pathogenesis 2019; 128: 184 doi: 10.1016/j.micpath.2019.01.004
|
27 |
|
28 |
Guangyun Tan, Hongxiao Song, Fengchao Xu, Genhong Cheng. When Hepatitis B Virus Meets Interferons. Frontiers in Microbiology 2018; 9 doi: 10.3389/fmicb.2018.01611
|
29 |
Alexandra Alexopoulou, Larisa Vasilieva, Peter Karayiannis. New Approaches to the Treatment of Chronic Hepatitis B. Journal of Clinical Medicine 2020; 9(10): 3187 doi: 10.3390/jcm9103187
|
30 |
Hong Tang, Mei-Fang Han, Ji-Ming Zhang. Acute Exacerbation of Chronic Hepatitis B. 2019; : 119 doi: 10.1007/978-94-024-1606-0_3
|